Several leading credit cards in 2026 feature attractive welcome bonuses and rewards tailored for travel, dining, and business expenses. The Chase Sapphire Preferred offers 75,000 bonus points after spending $5,000 in 3 months, plus travel perks like hotel credits and TSA PreCheck reimbursement for a $95 annual fee. Bank of America Travel Rewards provides 25,000 points after $1,000 spent with no annual fee and 0% intro APR for 15 months. The American Express Platinum Card offers up to 175,000 points after $12,000 spent in 6 months, plus extensive travel credits and lounge access for a $895 fee. Chase Freedom Unlimited and Ink Business Cash cards also provide strong cash back bonuses and rewards with no or low fees. These cards cater to different spending habits and credit profiles, making summer 2026 a good time to consider new credit card applications for maximizing rewards.
Jim Cramer criticized analysts' overenthusiasm for a few fintech stocks—SoFi, Klarna, and PayPal—calling for patience until these stocks drop before recommending them. Despite strong earnings, these fintech names have struggled with price declines du...
Director Carande has purchased 2,101 shares of United Community Banks. This insider buying may indicate confidence in the company's future prospects. Investors often view such transactions as a positive signal, potentially influencing market sentimen...
The Chase Ink Business Unlimited credit card provides a simple cash back option for business owners, offering a flat 1.5% cash back on all purchases with no annual fee. It features a limited-time $1,000 bonus cash back after spending $8,000 in the fi...
Defined-maturity bond ETFs like iShares iBonds Dec 2026 (IBDR), Invesco BulletShares 2028 (BSCS), and iShares iBonds Dec 2031 Treasury (IBTL) provide investors a way to lock in yields close to 5% by holding bonds that mature on fixed dates. Unlike tr...
J.P. Morgan Life Sciences Private Capital has named Bruce N. Rogers, Ph.D., as a Venture Partner. Dr. Rogers brings extensive experience in drug discovery and development, having led significant roles at Morphic Therapeutic and Pfizer. His expertise ...
